[{"address1": "1 Commonwealth Lane", "address2": "No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company also has Business & Research Collaboration Agreement with SunAct Cancer Institute Private Limited to conduct clinical trials for the GMP grade CTM-GDT. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 66, "title": "Executive Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 38143, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jieming  Zeng M.D., Ph.D.", "age": 50, "title": "Chief Scientific & Medical Officer and Director", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 102037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Goh", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk M.D.", "age": 38, "title": "Chief Clinical Officer", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 35, "title": "Chief Corporate Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.28, "open": 2.32, "dayLow": 2.32, "dayHigh": 2.32, "regularMarketPreviousClose": 2.28, "regularMarketOpen": 2.32, "regularMarketDayLow": 2.32, "regularMarketDayHigh": 2.32, "payoutRatio": 0.0, "beta": -0.288, "forwardPE": -15.466665, "volume": 398, "regularMarketVolume": 398, "averageVolume": 17703, "averageVolume10days": 11180, "averageDailyVolume10Day": 11180, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 26772800, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 4.05, "priceToSalesTrailing12Months": 53.18691, "fiftyDayAverage": 2.34288, "twoHundredDayAverage": 2.315235, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 22343432, "profitMargins": 0.0, "floatShares": 3593787, "sharesOutstanding": 11540000, "sharesShort": 73312, "sharesShortPriorMonth": 87660, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0064, "heldPercentInsiders": 0.68858004, "heldPercentInstitutions": 0.00317, "shortRatio": 6.76, "shortPercentOfFloat": 0.0223, "impliedSharesOutstanding": 11906200, "bookValue": 0.777, "priceToBook": 2.985843, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -2516698, "trailingEps": -0.17, "forwardEps": -0.15, "enterpriseToRevenue": 44.388, "enterpriseToEbitda": -7.977, "52WeekChange": 0.08411217, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 2.32, "recommendationKey": "none", "totalCash": 4970367, "totalCashPerShare": 0.431, "ebitda": -2800818, "totalDebt": 463250, "quickRatio": 8.393, "currentRatio": 9.892, "totalRevenue": 503372, "debtToEquity": 5.122, "revenuePerShare": 0.044, "returnOnAssets": -0.17441, "returnOnEquity": -0.24861, "grossProfits": 472325, "freeCashflow": -3173104, "operatingCashflow": -2709929, "revenueGrowth": 0.249, "grossMargins": 0.93832, "ebitdaMargins": 0.0, "operatingMargins": -5.3032203, "financialCurrency": "SGD", "symbol": "GDTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "CytoMed Therapeutics Limited", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1681479000000, "postMarketChangePercent": -0.862068, "postMarketPrice": 2.3, "postMarketChange": -0.02, "regularMarketChange": 0.03999996, "regularMarketDayRange": "2.32 - 2.32", "regularMarketChangePercent": 1.7543843, "regularMarketPrice": 2.32, "marketState": "CLOSED", "longName": "CytoMed Therapeutics Limited", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 17703, "fiftyTwoWeekLowChange": 1.1199999, "fiftyTwoWeekLowChangePercent": 0.9333332, "fiftyTwoWeekRange": "1.2 - 4.05", "fiftyTwoWeekHighChange": -1.7300003, "fiftyTwoWeekHighChangePercent": -0.42716053, "fiftyTwoWeekChangePercent": 8.411217, "earningsTimestamp": 1745870400, "earningsTimestampStart": 1745870400, "earningsTimestampEnd": 1745870400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.17, "epsForward": -0.15, "fiftyDayAverageChange": -0.022880077, "fiftyDayAverageChangePercent": -0.009765792, "twoHundredDayAverageChange": 0.0047650337, "twoHundredDayAverageChangePercent": 0.0020581211, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1748635445, "regularMarketTime": 1748635200, "exchange": "NCM", "messageBoardId": "finmb_647650276", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "CytoMed Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]